Sichuan Hebang Biotechnology (603077.SH) issued a profit warning, expecting a 96.88% to 97.66% year-on-year decline in net profit for the fiscal year 2024.
Habio (603077.SH) announces a decrease in performance forecast for the year 2024, expecting a decrease in net profit...
Sichuan Hebang Biotechnology (603077.SH) announced a forecasted decrease in performance for the year 2024, estimating a net profit attributable to shareholders of the listed company of 30 to 40 million yuan, a year-on-year decrease of 96.88% to 97.66%.
Related Articles
HK Stock Market Move | HBM HOLDINGS-B(02142) rose by more than 4% and deepened cooperation with AstraZeneca to jointly develop a new generation of tumor biotherapy.
BOCOM INTL: Maintains NIO-SW (09866) target price of 62.7 Hong Kong dollars. Rating "Buy". Positive cash flow indicates strong guidance.
HK Stock Market Move | HUAZHONG IN-V(06830) rose nearly 12% in early trading The company reached a cooperation agreement with MoLi Technology and focused on the four major directions in the field of intelligent recognition.
HK Stock Market Move | HBM HOLDINGS-B(02142) rose by more than 4% and deepened cooperation with AstraZeneca to jointly develop a new generation of tumor biotherapy.
BOCOM INTL: Maintains NIO-SW (09866) target price of 62.7 Hong Kong dollars. Rating "Buy". Positive cash flow indicates strong guidance.
HK Stock Market Move | HUAZHONG IN-V(06830) rose nearly 12% in early trading The company reached a cooperation agreement with MoLi Technology and focused on the four major directions in the field of intelligent recognition.
RECOMMEND
Hong Kong Stock Buyback Wave Persists, 247 Listed Companies Repurchase Over HKD 150 Billion This Year
27/11/2025
Mingyu Pharmaceutical Files With HKEX: Ongoing Net Losses Since Inception, No Revenue From Commercial Product Sales
27/11/2025
“Affordability Crisis”! Consumer Confidence Falls To Second Lowest Since The Pandemic, U.S. Retail Slumps
27/11/2025
